Vignatelli Luca, Baccari Flavia, Belotti Laura Maria Beatrice, Zenesini Corrado, Baldin Elisa, Calandra-Buonaura Giovanna, Cortelli Pietro, Descovich Carlo, Giannini Giulia, Guarino Maria, Loddo Giuseppe, Nassetti Stefania Alessandra, Sambati Luisa, Scaglione Cesa, Trombetti Susanna, D'Alessandro Roberto, Nonino Francesco
UOSI Epidemiologia e Statistica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Dipartimento di Scienze Biomediche e NeuroMotorie, Università degli Studi di Bologna, Bologna, Italy.
Front Neurol. 2022 May 16;13:873925. doi: 10.3389/fneur.2022.873925. eCollection 2022.
The indirect impact of the COVID-19 epidemic on major clinical outcomes of people with Parkinson's disease (PD) or other parkinsonism is unknown.
The study aimed to (1) describe changes in healthcare services during the first epidemic bout in people with PD or parkinsonism; (2) compare the occurrence of hospitalization for any PD-related major clinical outcomes in 2020 with 2019; (3) investigate the factors, including changes in healthcare services, associated with major clinical outcomes and death.
All healthcare services of the province of Bologna and major clinical outcomes were assessed through a record linkage study (ParkLink Bologna) using clinical data and health databases. Same analyses were performed in a random cohort of controls matched for age, sex, district of residence, and comorbidities with the ParkLink cohort (ratio of 1:10).
A cohort of subjects with PD (759) or other parkinsonism (192) was included together with a cohort of controls (9,226). All indicators of healthcare services dropped at least below 50% during the lockdown period in all cohorts, mostly impacting physiotherapy in people with PD (-93%, 95% CI 88-96%). In 2020, compared to 2019, a three-fold risk of major injuries (RR 3.0, 95% CI 1.5-6.2) and infections (RR 3.3, 95% CI 1.5-7.2), excluding COVID-19, was observed only in people with PD, and neither in people with parkinsonism nor in controls. Decreased physiotherapy was associated with the occurrence of at least one major clinical outcome (OR 3.3, 95% CI 1.1-9.8) in people with PD. Experiencing at least one major clinical outcome was the strongest risk factor for death (OR 30.4, 95% CI 11.1-83.4) in people with PD.
During the first COVID-19 epidemic peak, healthcare services were drastically reduced in a province of northern Italy, regardless of the disease condition. However, compared to 2019, in 2020, only people with PD had a higher risk of major clinical outcomes, that were associated with higher mortality. Strategies to maintain physical activity in people with PD should be implemented in possible future health emergencies.
2019冠状病毒病(COVID-19)疫情对帕金森病(PD)患者或其他帕金森综合征患者主要临床结局的间接影响尚不清楚。
本研究旨在(1)描述PD或帕金森综合征患者在疫情首轮爆发期间医疗服务的变化;(2)比较2020年与2019年因任何与PD相关的主要临床结局而住院的发生率;(3)调查与主要临床结局和死亡相关的因素,包括医疗服务的变化。
通过一项记录链接研究(博洛尼亚帕金森病链接研究[ParkLink Bologna]),利用临床数据和健康数据库,评估博洛尼亚省的所有医疗服务和主要临床结局。在一个与ParkLink队列年龄、性别、居住地区和合并症相匹配的随机对照队列(比例为1:10)中进行同样的分析。
纳入了一组PD患者(759例)或其他帕金森综合征患者(192例)以及一组对照(9226例)。在封锁期间,所有队列中医疗服务的所有指标至少下降到50%以下,主要影响了PD患者的物理治疗(下降93%,95%置信区间88%-96%)。与2019年相比,2020年,仅在PD患者中观察到严重损伤(风险比[RR]3.0,95%置信区间1.5-6.2)和感染(RR 3.3,95%置信区间1.5-7.2)的风险增加了两倍,帕金森综合征患者和对照中均未观察到。物理治疗减少与PD患者至少发生一项主要临床结局相关(比值比[OR]3.3,95%置信区间1.1-9.8)。发生至少一项主要临床结局是PD患者死亡的最强危险因素(OR 30.4,95%置信区间11.1-83.4)。
在COVID-19疫情的首个高峰期间,意大利北部一个省份的医疗服务大幅减少,与疾病状况无关。然而,与2019年相比,2020年只有PD患者发生主要临床结局的风险更高,且这些结局与更高的死亡率相关。在未来可能发生的卫生紧急情况中,应实施维持PD患者身体活动的策略。